InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 16
In This Article:
LONDON, UNITED KINGDOM / ACCESSWIRE / October 16, 2024 / The Company announces that on 15 October 2024 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
| Date of purchase: | 15 October 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
The Company intends to cancel the purchased shares.
Following the above transaction, the Company has 159,235,452 ordinary shares in issue (excluding 6,956,782 held in treasury).
A full breakdown of the individual purchases by GSI is included below.
Enquiries to:
InterContinental Hotels Group PLC:
Investor Relations: Stuart Ford (+44 (0)7823 828 739);
Joe Simpson (+44 (0)7976 862 072)
Media Relations: Mike Ward (+44 (0)7795 257 407)
Schedule of Purchases
Shares purchased: 1,000 (ISIN: GB00BHJYC057)
Date of purchases: 15 October 2024
Investment firm: GSI
Aggregated information:
| London Stock Exchange | Cboe BXE | Cboe CXE | Turquoise | |
| Number of ordinary shares purchased | 1,000 | |||
| Highest price paid (per ordinary share) | ￡ 85.6800 | |||
| Lowest price paid (per ordinary share) | ￡ 84.1800 | |||
| Volume weighted average price paid(per ordinary share) | ￡ 84.8137 |
Detailed information:
| Transaction Date | Time | Time Zone | Volume | Price (GBP) | Trading Venue | Transaction ID |
| 15/10/2024 | 09:43:43 | BST | 48 | 85.6800 | XLON | 1088585910459081 |
| 15/10/2024 | 09:44:13 | BST | 45 | 85.6600 | XLON | 1088585910459213 |
| 15/10/2024 | 10:14:34 | BST | 40 | 85.3400 | XLON | 1088585910461559 |
| 15/10/2024 | 10:49:46 | BST | 44 | 85.1000 | XLON | 1088585910464256 |
| 15/10/2024 | 11:28:00 | BST | 42 | 84.9600 | XLON | 1088585910466143 |
| 15/10/2024 | 12:08:23 | BST | 40 | 84.8400 | XLON | 1088585910467872 |
| 15/10/2024 | 12:49:51 | BST | 40 | 84.8200 | XLON | 1088585910469566 |
| 15/10/2024 | 13:29:55 | BST | 41 | 84.7600 | XLON | 1088585910471795 |
| 15/10/2024 | 14:06:37 | BST | 40 | 84.9800 | XLON | 1088585910474753 |
| 15/10/2024 | 14:38:40 | BST | 40 | 84.9400 | XLON | 1088585910476516 |
| 15/10/2024 | 15:01:29 | BST | 25 | 84.8000 | XLON | 1088585910477999 |
| 15/10/2024 | 15:01:29 | BST | 15 | 84.8000 | XLON | 1088585910478000 |
| 15/10/2024 | 15:26:18 | BST | 40 | 84.5800 | XLON | 1088585910479445 |
| 15/10/2024 | 15:35:05 | BST | 40 | 84.8600 | XLON | 1088585910481422 |
| 15/10/2024 | 15:47:20 | BST | 40 | 84.8400 | XLON | 1088585910482832 |
| 15/10/2024 | 15:56:04 | BST | 40 | 84.8200 | XLON | 1088585910483764 |
| 15/10/2024 | 16:05:15 | BST | 40 | 84.7800 | XLON | 1088585910484867 |
| 15/10/2024 | 16:13:16 | BST | 40 | 84.8800 | XLON | 1088585910485834 |
| 15/10/2024 | 16:23:07 | BST | 40 | 84.9000 | XLON | 1088585910487612 |
| 15/10/2024 | 16:33:48 | BST | 40 | 84.5400 | XLON | 1088585910490258 |
| 15/10/2024 | 16:48:30 | BST | 39 | 84.2800 | XLON | 1088585910492882 |
| 15/10/2024 | 16:48:30 | BST | 1 | 84.2800 | XLON | 1088585910492883 |
| 15/10/2024 | 17:01:15 | BST | 24 | 84.3200 | XLON | 1088585910494636 |
| 15/10/2024 | 17:01:15 | BST | 17 | 84.3200 | XLON | 1088585910494637 |
| 15/10/2024 | 17:10:26 | BST | 25 | 84.2800 | XLON | 1088585910496185 |
| 15/10/2024 | 17:10:26 | BST | 17 | 84.2800 | XLON | 1088585910496186 |
| 15/10/2024 | 17:18:55 | BST | 40 | 84.3600 | XLON | 1088585910497895 |
| 15/10/2024 | 17:24:51 | BST | 41 | 84.1800 | XLON | 1088585910499633 |
| 15/10/2024 | 17:26:18 | BST | 4 | 84.2400 | XLON | 1088585910500035 |
| 15/10/2024 | 17:26:18 | BST | 12 | 84.2400 | XLON | 1088585910500036 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.